<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02731456</url>
  </required_header>
  <id_info>
    <org_study_id>REB15 - 2709_MOD1</org_study_id>
    <nct_id>NCT02731456</nct_id>
  </id_info>
  <brief_title>Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance in Lowlanders</brief_title>
  <official_title>Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance and Sleep Quality in Lowlanders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marc Poulin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective interventional trial in lowlanders evaluating the effect of acute exposure,&#xD;
      acclimatization and re-exposure to high altitude on psychomotor vigilance to measure&#xD;
      sustained attention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baseline measurements will be performed in Santiago de Chile, 520 m, over the course of 3&#xD;
      days. Participants will then travel by commercial airline (2 h flight) and by bus (2 h ride)&#xD;
      to the ALMA base camp located at 2900 m near San Pedro de Atacama, northern Chile.&#xD;
      Participants will stay there for the next 7 nights and they will spend the days (6 total; 6-8&#xD;
      h daily) at the telescope station at 5050 m while undergoing testing as described above at&#xD;
      the first and the last day at 5050m. Daily transports from 2900 to 5050 m will be by car (1 h&#xD;
      ride, one way). After the first 7 day altitude sojourn participants will return to the&#xD;
      Santiago area (520 m) for a 7 day recovery period. A second altitude sojourn with an&#xD;
      identical schedule as the one described above and a final low altitude stay of 3 days will&#xD;
      follow.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sustained attention measured by a visual pychomotor vigilance test (PVT)</measure>
    <time_frame>Low altitude dojourn at 520m; forst sojourn at 5050m Day 2, 7; second sojourn at 5050m Day 2, 7</time_frame>
    <description>Change in psychomotor response speed across two cycles of altitude exposure, comparing 5050m to 520m.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Indices of sleep quality measured by actigraphy (total sleep time, sleep efficiency, sleep latency</measure>
    <time_frame>Low altitude dojourn at 520m; forst sojourn at 5050m Day 2, 7; second sojourn at 5050m Day 2, 7</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">18</enrollment>
  <condition>Effect of High Altitude</condition>
  <arm_group>
    <arm_group_label>Altitude exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acute high altitude exposure followed by 8 day acclimatization and re-exposure for 8 days after 6 days at low altitude.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>altitude exposure</intervention_name>
    <description>altitude exposure</description>
    <arm_group_label>Altitude exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  born, raised and currently living &lt;1300m&#xD;
&#xD;
          -  No overnight stays at altitudes &gt;1500m 4 weeks before the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous altitude intolerance &lt;3000m&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  health impairment, which requires regular treatment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc J Poulin, PhD, DPhil</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Calgary</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T2N 4N1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 3, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2016</study_first_posted>
  <last_update_submitted>April 23, 2018</last_update_submitted>
  <last_update_submitted_qc>April 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Marc Poulin</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>high altitude</keyword>
  <keyword>cognition</keyword>
  <keyword>sleep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

